Adagene (ADAG) Current Deferred Revenue (2019 - 2025)

Adagene (ADAG) has 6 years of Current Deferred Revenue data on file, last reported at $3462.7 billion in Q4 2025.

• On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $3462.7 billion in Q4 2025; TTM through Dec 2025 was $3462.7 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $3462.7 billion, changed N/A from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $3462.7 billion, up from $812.9 billion in the prior quarter.
• Over the last five years, Current Deferred Revenue for ADAG reached as high as $20176.8 billion in Q2 2022 and fell as low as $5.5 million in Q4 2021.
• Historically, Current Deferred Revenue has averaged $6593.3 billion across 4 years, with a median of $2137.8 billion in 2023.
• Across the five-year window, Current Deferred Revenue soared 274677645.45% in 2022 and plunged 95.97% in 2023, its largest moves.
• Year by year, Current Deferred Revenue stood at $5.5 million in 2021, then surged by 274677645.45% to $15107.3 billion in 2022, then tumbled by 94.62% to $812.9 billion in 2023, then surged by 325.96% to $3462.7 billion in 2025.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $3462.7 billion in Q4 2025, $812.9 billion in Q2 2023, and $15107.3 billion in Q4 2022.